Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from p...

ZOETIS INC. (ZTS) has a valuation score of 95/100 (strong), profitability score of 87/100 (strong), financial health score of 80/100 (strong), Piotroski F-Score of 7/9, Altman Z-Score of 3.62 (safe zone), revenue growth of +5.4% YoY.

Neutral

Analyst Consensus

Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations24 analysts · 2026-08-01
5
8
11
Strong Buy 5Buy 8Hold 11Sell 0Strong Sell 0

Recent Market Moves

See all ZTS moves →
DateSessionPriceMoveZ-Score
Aug 7Regular$72.64-5.99%-3.99
Aug 7After-hours$73.09-5.41%-3.61
Aug 6Regular$77.18+3.75%2.50
Aug 6After-hours$78.00+4.85%3.24
Aug 5After-hours$73.70-3.08%-2.05